Mirai Medical Service

Mirai Medical Service Co., Ltd. specializes in investment and operation management in regenerative medicine. Currently, its market share of cell culture media for tissue culture in Japan is approximately 70%. The company focuses on building a regenerative medicine-centered business model while gradually establishing an industrial structure composed of "five key sectors": regenerative medicine as the core, along with cell culture, clinical applications, product development, medical services, and remote diagnosis collaboration.